Advertisement

Atopic Dermatitis

  • Vered Atar-Snir
Chapter

Abstract

Atopic Dermatitis (AD) is a chronic pruritic inflammatory skin disease.

The etiology is unknown. It usually starts in early infancy, but also affects adults.

It is often associated with elevated serum level of immunoglobulin E and personal or family history of eczema, asthma and allergic rhinitis.

Female to male ratio 1.14:1.

Treatment goals are to reduce symptoms (pruritus and dermatitis), prevent exacerbations and minimize therapeutic risks.

References

  1. 1.
    Sprengel JM. From atopic dermatitis to asthma: the atopic march. Am Allergy Asthma Immunol. 2010;105:99.CrossRefGoogle Scholar
  2. 2.
    Schlapbach C, Simon D. Update on skin allergy. Allergy. 2014;69:1571–81.CrossRefGoogle Scholar
  3. 3.
    Brown MM, Chamlin SL. Quality of life in pediatric dermatology. Dermatol Clin. 2013;31:211–21.CrossRefGoogle Scholar
  4. 4.
    Carroll CL, Balkrishnan R, Feldman SR, et al. The burden of atopic dermatitis: impact on the patent, family and society. Pediatr Dermatol. 2005;22:192–9.CrossRefGoogle Scholar
  5. 5.
    Asher MI, Montfort S, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis and eczema in childhood. Lancet. 2006;368(9537):733–43.CrossRefGoogle Scholar
  6. 6.
    William HC. Atopic dermatitis. N Engl J Med. 2005;352(22):2314–66.CrossRefGoogle Scholar
  7. 7.
    Pesce G, Harcon A, Carosso A, et al. Adult eczema in Italy: prevalence and associations with environmental factors. J Eur Acad Dermatol Venerol. 2015;29(6):1180–7.CrossRefGoogle Scholar
  8. 8.
    Wohly Y, Wainstein J, Bar-Dayan Y. Atopic dermatitis in Israeli adolescents—a large retrospective cohort study. Acta Derm Venereol. 2014;94(6):695–8.CrossRefGoogle Scholar
  9. 9.
    Ziyab HA, Raza A, Karmaus W, et al. Trends in eczema in the first 18 years of life. Results from the isle of Wight birth cohort study. Clin Exp Allerg. 2010;40(12):1776–84.CrossRefGoogle Scholar
  10. 10.
    Simonsen AB, Deleuran M, et al. Allergic contact dermatitis in Danish children referred from patch testing—a nationwide multicenter study. Contact Dermatitis. 2014;70(2):104–11.CrossRefGoogle Scholar
  11. 11.
    Hwang CY, Chen YJ, Lin MW, et al. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan. A national study 2000–2007. Acta Derm Venereol. 2010;96(6):589–94.Google Scholar
  12. 12.
    Tay YK, Khool L, Cl G, Giam YC. The prevalence and descriptive epidemiology of atopic dermatitis in Singapore school children. Br J Dermatol. 2002;146(1):101–6.CrossRefGoogle Scholar
  13. 13.
    Shamssain MH, Shamsian N. Prevalence and severity of asthma, rhinitis and atopic eczema in 13–14 years old school children from northeast of England. Ann Allergy Asthma Immunol. 2001;86(4):428–32.CrossRefGoogle Scholar
  14. 14.
    Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis. Section 1: diagnosis and assessment of atopic dermtitis. J Am Acad Dermatol. 2014;70:338.CrossRefGoogle Scholar
  15. 15.
    Schultz LF. Atopic dermatitis: a genetic epidemiologic study in a population based twin sample. J Am Acad Dermatol. 1993;28:719.CrossRefGoogle Scholar
  16. 16.
    Palmer CNA, Irvine AD, et al. Common loss of function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441–6.CrossRefGoogle Scholar
  17. 17.
    Strachan DP. Hay fever, hygiene and household size. Br Med J. 1989;299(6710):1259–60.CrossRefGoogle Scholar
  18. 18.
    Von Mutius E. Maternal farm exposure ingestion of unpasteurized cow milk and allergic disease. Curr Opin Gastroenterol. 2012;28:570–6.CrossRefGoogle Scholar
  19. 19.
    De Bendetto A, Kubo A, Beck LA. Skin barrier disruption: a requirement for allergen sensitization. J Invest Dermatol. 2012;132(3):949–63.CrossRefGoogle Scholar
  20. 20.
    Thomsen SF. Atopic dermatitis: natural history diagnosis and treatment. ISRN Allergy. 2014;2014:354250.CrossRefGoogle Scholar
  21. 21.
    Eyerich K, Novak N. Immunology of atopic eczema overcoming the Th1/Th2 paradigm. Allergy. 2013;68:974–82.CrossRefGoogle Scholar
  22. 22.
    Leung DYM, Guttmn-Yassky E. Diciphering the complexties of atopic dermatitis shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134:769.CrossRefGoogle Scholar
  23. 23.
    Radikoff D, Lebwohl M. Atopic dermatitis. Lancet. 1998;351:1715.CrossRefGoogle Scholar
  24. 24.
    William L Weston, William Howe. Atopic dermatitis (eczema), pathogenesis, clinical manifestation and diagnosis. Uptodate 10/2017.Google Scholar
  25. 25.
    Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352:2314.CrossRefGoogle Scholar
  26. 26.
    Williams HC, et al. The UK working party‘s diagnostic criteria for atopic dermatitis. BR J Dermat. 1994;131:406.CrossRefGoogle Scholar
  27. 27.
    Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema. J Eur Acad Dermatol Venereol. 2012;26:1045–60.CrossRefGoogle Scholar
  28. 28.
    Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis section 2: management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71:116.CrossRefGoogle Scholar
  29. 29.
    Sibbury R, Davis DM, Cogen DE, et al. Guidelines of care for the management of atopic dermatitis section 3: management and treatment with phototherpy and systemic agents. J Am Acad Dermatol. 2014;71:327.CrossRefGoogle Scholar
  30. 30.
    Simpson EL. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin. 2010;26(3):633–40.CrossRefGoogle Scholar
  31. 31.
    Ricci G, Dondi A, Patrizi A. Useful tools for the management of atopic dermatitis. Am J Clin Dermatol. 2009;10(5):287–300.CrossRefGoogle Scholar
  32. 32.
    Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess. 2000;4:1.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Green C, Colquitt JL, Kirby J, et al. Clinical and cost effectiveness of once daily versus more frequent use of same potency topical corticosteroids for atopic eczema. A systematic review and economic evaluation. Health Technol Assess. 2004;8(47):1–120.CrossRefGoogle Scholar
  34. 34.
    El-Batawy MMY, Bassrila MA, Mashaly HM. Topical calcineurin inhibitors in atopic dermatitis: a systemic review and meta-analysis. J Dermatol Sci. 2009;54(2):76–87.CrossRefGoogle Scholar
  35. 35.
    Ascroft DM, Dimmock P, Garside R, et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis; meta-analysis of randomized controlled trials. Br Med J. 2005;330:516.CrossRefGoogle Scholar
  36. 36.
    Garristen FM, Brouner MW. Photo (chemo) therpy in the management of atopic dermatitis: and updated systematic review with implications for practice and research. Br J Dermatol. 2014;170:501.CrossRefGoogle Scholar
  37. 37.
    Stern RS, Nicholsky KT. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet radiation (PUVA) the PUVA follow up study. N Engl J Med. 1997;336:1041.CrossRefGoogle Scholar
  38. 38.
    Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part II. J Eur Acad Dermatol Venereol. 2012;26:1176.CrossRefGoogle Scholar
  39. 39.
    Beck LA, Thaci D, Hamilton JD, et al. Dupilumab treatment in adults with moderate to severe atopic dermatitis inadequately controlled by topical treatment: a randomized, placebo controlled dose ranging phase IIB trial. Lancet. 2016;387:40.CrossRefGoogle Scholar
  40. 40.
    Pajno GB, Caminitil L, Vita D, et al. Sublingual immunotherapy in mite sensitized children with atopic dermatitis; a randomized, double blind, placebo controlled study. J Allergy Clin Immunol. 2007;120:164.CrossRefGoogle Scholar
  41. 41.
    Bissonnette R, Papp KA, Poulin Y, et al. Topical tofacitinib for atopic dermatitis a phase IIa randomized trial. Br J Dermatol. 2016;175:902.CrossRefGoogle Scholar
  42. 42.
    Ruzicka T, Hanifin JM, Furue M, et al. Anti interleukin-31 receptor A antibody for atopic dermatitis. N Engl J Med. 2017;376:826.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Clalit Health Care ServicesTel AvivIsrael
  2. 2.Schneider Children‘s Medical CenterPetah TikvaIsrael

Personalised recommendations